Pasgala, Christela N.

HRN: 22-00-59  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2022
CEFUROXIME 750MG (VIAL)
10/02/2022
10/09/2022
IV
1.5 Gms
Q 8 HRS
TMSAF
Waiting Final Action 
10/02/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/02/2022
10/09/2022
IV
500 Mg
Q 8 HRS
TMSAF
Waiting Final Action 
10/02/2022
CEFUROXIME 500MG (TAB)
10/02/2022
10/09/2022
ORAL
1 Tab
Q12H
Thickly MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: